ĀÜĄņĀŅĀ×

Dr. Ferzaan Engineer is Co-founder and Chairman of Cytecare Hospitals. He is also the Co-founder and Joint Chairman of Medwell Ventures, which offers home healthcare services under the Nightingales brand. Ferzaan serves on the Board of Directors of Sun Pharma Advanced Research Company Ltd (SPARC) and Cytespace Research Pvt Ltd. He is an Observer on the Board of AUM Biosciences, Singapore. He is a mentor at Escape Velocity Accelerator (EVA) in Bangalore. Ferzaan helped launch the international CRO industry in India and served as Chairman and CEO of Quintiles India from 1997 to 2010. He was also a member of the Quintiles Asia-Pacific Management Board. He has also served on the Board of Cenduit LLC and on the Scientific Advisory Boards of Cellworks, USA and Image Core Lab, India. A graduate of the LM College of Pharmacy in Ahmedabad, Ferzaan completed his PhD in Pharmaceutical Sciences from the University of South Carolina, USA. He attended executive management programs at INSEAD (France), IIMA (India) and the Kenan-Flagler Business School (USA).

Ferzaan has previously worked as Assistant Professor of Pharmaceutical Sciences in the United States, followed by an industry position as Vice President of Research for Core Healthcare. He has been a member of professional bodies such as AAPS and AACP. He received the AACP New Investigatorā€™s Award in 1990 and received research grants from the National Institutes of Health (NIH), USA. He has published papers in leading international journals and lectured at several conferences and at management schools such as IIMA and the Judge Business School at the University of Cambridge. He has served on the Advisory Board of the Indian Society for Clinical Research (ISCR) and has been a member of the CII National Committee on Drugs and Pharmaceuticals and the FICCI Pharmaceuticals and Biotechnology Committee.